Big pharma fears US-EU tariff war will hit top drugs | REUTERS
0:00 / 0:00
John
English
Professionals
Professional Academic
Make your video stand out in seconds. Adjust voice, language, style, and audience exactly how you want!
Summary
Pharmaceutical companies are urging the Trump Administration and EU to exclude medical goods from tariff expansions to avoid price increases on key drugs. They argue that tariffs could jeopardize drug pricing initiatives and American life expectancy. Some companies are considering US manufacturing expansions while seeking tax breaks and regulatory changes amid rising tariff tensions.